A Durham company has raised $21 million in venture capital to chase every surgeon's dream: to cure without cutting.
TransEnterix is a brain child of Synecor, a business incubator that spun out of Duke University seven years ago to turn medical device ideas into money makers. The cash -- not a record amount but a lot for a tiny, barely operational Triangle company -- will allow TransEnterix to hire six engineers, build models of a medical device and, if all goes well, begin testing the device in about two years on patients undergoing abdominal surgery.
